All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Bile and liver therapy

Iqirvo

(elafibranor)

Uses, side effects, dosage information & price range

Ipsen Pharma

About this medicine

Iqirvo is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

BylvayComposition: odevixibatIpsen Pharma
Price on RequestView Details →
Lyvdelzi (previously Seladelpar Gilead)Composition: seladelpar lysine dihydrateGilead Sciences Ireland Unlimited Company
Price on RequestView Details →
RezdiffraComposition: resmetiromMadrigal Pharmaceuticals EU Limited
Price on RequestView Details →
Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau)Composition: chenodeoxycholic acidLeadiant GmbH
Price on RequestView Details →
KayfandaComposition: odevixibatIpsen Pharma
Price on RequestView Details →

Key Information

Salt / Composition

elafibranor

Category

Bile and liver therapy

Manufacturer

Ipsen Pharma

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.